Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences — Kansas City, Missouri

Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences is a clinical research site located in Kansas City, Missouri, United States 64106.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences has participated in 1 clinical trials.

Therapeutic areas: Healthy Volunteers.

Sponsors: Kansas City University of Medicine and Biosciences.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences?

Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences conducted?

Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences has 1 clinical trials on record. Their work covers Healthy Volunteers.

Is Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences accredited by Crixeo Health?

Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.